LatestIP And Trademarks 19 September 2026
Indian Pharma Wins Patent for Insulin Eye Drops
An Indian pharmaceutical company has been granted a patent for a novel topical insulin eye‑drop formulation designed to accelerate corneal healing. The breakthrough could offer a new treatment option for patients with corneal injuries or post‑surgical recovery, potentially improving outcomes and reducing reliance on existing therapies.
Patent granted for insulin eye drops
- The Indian firm secured a patent for a topical insulin formulation aimed at repairing corneal damage.
- Intended to speed up healing after injuries or surgery, offering an alternative to current treatments.
- The development may open new market opportunities in ophthalmic care.
Read the full story on the original source: Indian pharmaceutical firm secures patent for topical insulin eye drops to aid corneal repair
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.